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Blastocyst formation is blocked in mouse embryos lacking the
splicing factor SRp20
Hassan Jumaa, Grace Wei and Peter J. Nielsen
SRp20 is a splicing factor belonging to the highly
conserved family of SR proteins [1–4], which have
multiple roles in the regulation of constitutive and
alternative splicing in vivo. It has been suggested that
SR proteins are involved in bringing together the splice
sites during spliceosome assembly [5]. SR proteins show
partial redundancy, as each single SR protein can
restore splicing activity to a splicing-deficient
cytoplasmic extract (termed S-100 extract). Nevertheless,
several studies demonstrate that individual SR proteins
have different effects on the selection of specific
alternative splice sites, and they recognize distinct RNA
sequences [6–12]. Also, inactivation of two SR proteins,
B52/SRp55 in Drosophila [13] or ASF/SF2 in the chicken
cell line DT40 [14], is lethal, indicating the existence of
nonredundant functions. Here, using Cre–loxP-mediated
recombination in mice to inactivate the SRp20 gene, we
found that it is essential for mouse development. Mutant
preimplantation embryos failed to form blastocysts and
died at the morula stage. Immunofluorescent staining
showed that SRp20 is present in oocytes and early
stages of embryonic development. This is the first report
of mice deficient for a member of the SR protein family.
Our experiments confirm that, although similar in
structure, the SR proteins are not functionally redundant.
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Results and discussion
To study the requirement for SRp20 during mouse embry-
onic development and in different tissues, we constructed a
vector for conditional gene targeting using the loxP system
(Figure 1) [15]. The strategy was aimed at deleting exons 2
and 3, which encode the entire RNA-binding domain of
SRp20 [16]. The targeting construct (SRp20loxP) was elec-
troporated into embryonic stem (ES) cells. From 480 ES
cell clones, one was found which showed the expected con-
figuration in a Southern blot and was injected into mouse
blastocysts. Chimeric mice were obtained, which transmit-
ted the targeted allele to their offspring.
Intercrossing the heterozygous mice led to offspring
homozygous for the allele containing the loxP sites or the
‘floxed’ allele (p allele). These mice were normal and
fertile, and RT–PCR analysis (data not shown) of SRp20
Figure 1
Targeting of the murine SRp20 gene using the Cre–loxP system.
(a) The SRp20loxP targeting vector has three loxP sites (filled
triangles). The tandem neo and TK cassettes are flanked by two loxP
sites (filled triangles) and are inserted into the first intron of the SRp20
gene. A third loxP site is in intron 3. The two right-angled arrows below
the neo–TK cassette indicate the direction of transcription of the neo
and TK genes. (b) Genomic structure of the SRp20 gene. Numbered
boxes, exons; lines, introns; dashed lines, regions of homology where
crossover can take place. (c) Expected configuration of the SRp20
gene locus after homologous recombination (the p allele). The asterisks
indicate the locations of primers used for genotyping of embryos by
PCR. (d) The expected SRp20 gene structure after Cre-mediated
recombination (the d allele). Recombination was achieved by crossing
the mice bearing the p allele with Cre-expressing mice. (e) After
electroporation of the targeting vector into a BALB/C ES cell line, DNA
from an ES cell clone, which was identified by PCR, was digested with
PstI and hybridized with the 5′ and 3′ probes indicated in (c). The
fragment sizes are as expected and are indicated on the right; +/+, wild
type; +/p, heterozygous for the p allele. This ES cell clone gave rise to
chimeric mice with germ-line transmission. (f) The genomic structure of
the d allele was confirmed by Southern blot hybridization after ApaI
digestion; +/d, heterozygous for the d allele.
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transcripts in organs of these mice revealed that the pres-
ence of the neo–TK cassette containing two poly(A) sites
did not disturb SRp20 expression. Crossing the mice
homozygous for the floxed allele with mice ubiquitously
expressing the Cre recombinase [17] resulted in mice with
an inactivated SRp20 allele (d allele). When the offspring
derived from intercrosses of SRp20+/d mice were geno-
typed, we found that homozygous mutants were absent
and about half of the heterozygotes were lost (Table 1),
causing a reduced litter size. 
To determine the stage of development at which the
homozygotes died, we first examined embryos from
SRp20+/d intercrosses at 10 days post coitum (dpc). All
embryos were either wild type or heterozygous, suggest-
ing that embryonic lethality occurred earlier during
development. Preimplantation embryos were therefore
analyzed. At 2.5 dpc, 8-cell embryos were recovered and
genotyped by PCR. The number of homozygous mutant
embryos was close to the expected Mendelian ratio
(Table 1). When embryos from intercrosses were col-
lected at 3.5 dpc and genotyped by PCR, it became clear
that none of the homozygous mutants reached the blasto-
cyst stage by 3.5 dpc, but rather were found among a pop-
ulation of obviously growth-inhibited morulae (Table 1).
These results suggest that embryos lacking a functional
SRp20 gene fail to develop beyond the morula stage. To
confirm this, we recovered 147 morulae from SRp20+/d
intercrosses at 3 dpc and cultured them in vitro (Figure 2).
After one day in culture (corresponding to 4 dpc),
embryos were genotyped by PCR (Figure 2). None of the
blastocysts (50) were homozygous for the mutation
(Table 2). On the following day (5 dpc), additional
embryos were PCR-genotyped and again, none of the
blastocysts (17) were found to be homozygous for the
mutation. At the same time, of the 33 degenerated
morulae examined (Figure 2 and Table 2), 27 were
homozygous for the SRp20-mutated allele. This strongly
supports the idea that a homozygous mutant embryo
cannot form a blastocyst and dies because it lacks SRp20. 
One obvious question is whether SRp20 is required at
the morula stage for the first time during development or
whether earlier requirements for SRp20 are met by
maternally supplied protein. We examined the levels of
SRp20 protein in preimplantation embryos at different
stages using the monoclonal antibody 7B4, which is spe-
cific for SRp20 [18]. Figure 3 shows that SRp20 was
present throughout the embryonic stages tested (oocyte,
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Table 1
Genotypes of progeny from SRp20+/d intercrosses.
Age Genotype
+/+ +/d d/d
4 weeks 66 56 0
2.5 dpc 15 34 17
3.5 dpc 10 18 12*
*No blastocysts were found among the d/d embryos at 3.5 days
post coitum (dpc).
Figure 2
(a) (b) (c)
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In vitro development of preimplantation embryos. (a) At 3 dpc, 147
morulae were collected and cultured in M16 medium [19] at 37°C in
the presence of 7.5% CO2. (b) After 1 day in culture, 95 embryos
were recovered and genotyped by PCR. Of these embryos, 50 were at
the blastocyst stage; this image shows an example. Most of these
embryos were at the blastocyst stage. (c) After 2 days in culture, an
additional 17 blastocysts and 34 obviously defective morulae were
recovered and PCR-genotyped (Table 2). For PCR genotyping, the
nested primers shown in Figure 1c (within intron 1, exon 3 and intron
3) were used. With this PCR strategy, the wild-type allele produced a
band of 471 bp, resulting from amplification of sequences between
exon 3 and intron 3. The distance between the intron 1 and intron 3
primers in the wild-type allele is too large for amplification. After Cre-
mediated recombination, a portion of the SRp20 locus that includes
exons 2 and 3 is deleted, and the d allele generates a PCR fragment of
531 bp. Representative PCR results are shown at the bottom of (b,c).
The upper band is the PCR product from the d allele; the lower band is
the product from the wild-type allele.
fertilized egg, 8-cell embryo, blastocyst), indicating that
maternal SRp20 is packaged into the developing egg.
Stained embryos derived from SRp20+/d intercrosses
revealed that the nuclear signal for maternal SRp20 was
strongly reduced by the 8-cell stage in homozygous
mutant embryos. Because the embryos died as late
morulae, it is not clear whether there is residual SRp20 in
8-cell embryos, which was not detected by immunofluo-
rescent staining, or whether SRp20 is not essential
before the blastula stage. The abundance of SRp20 tran-
scripts during early embryonic development was esti-
mated by a computer-aided search for SRp20 sequences
in mouse expressed sequence tag (EST) libraries. SRp20
transcripts appeared to be very rare at the 2-cell stage (no
matches in 13,132 sequences) but were increased at the
8-cell stage to a frequency of 1.5 per 103 clones (3,443
entries examined). This is consistent with the phenotype
we observed for mutant embryos, in which the very early
stages of embryonic development appeared normal. The
frequency of SRp20 EST clones in blastocyst libraries
was about 0.4 per 103 clones (19,952 entries examined),
suggesting a possible drop in transcript abundance at
this stage.
As the blastocyst is the first developmental stage with
known differentiated lineages (the trophectoderm and the
inner cell mass), SRp20 may be essential for this differen-
tiation. Taken together, the above results show for the
first time the absolute requirement for an SR protein in
early vertebrate development. Together with the reported
findings for SRp55 [13] and ASF/SF2 [14], these results
contribute to the general picture that the SR family com-
prises essential proteins, which are not functionally redun-
dant. Clearly, the challenge for the future is to clarify the
different role that each SR protein plays, both during dif-
ferentiation and in mature cells.
Materials and methods
Plasmid construction
A single loxP site was inserted between a 4.7 kb XmnI–StuI fragment
(spanning intron 1 to intron 3) and a 4.9 kb StuI–BamHI fragment (span-
ning intron 3 to exon 7). Subsequently, a neo–TK cassette flanked by
two loxP sites was inserted at the PacI site of intron 1 to generate the
targeting vector SRp20loxP.
PCR genotyping of preimplantation embryos 
Embryos were lysed in PCR tubes by three cycles of freeze and boil,
and half of the lysate was used in a nested PCR. The PCR primers for
the SRp20 gene were located in intron 1 (Xi1: 5′-TTGATTGC-
GACAGGACTTT-3′ and Xi1i: 5′-CTGCCTGGCCTCAAACTT-3′),
exon 3 (X16X3: 5′-GATTACCGCAGGAGGAGT-3′ and X16X3i: 5′-
GCGCAGGTACTTGAGAGA-3′) and intron 3 (Xi3R: 5′-AGAACG-
GATGATTGGGAA-3′ and Xi3Ri: 5′-CCCTTTTATTGGTCAGTGA-3′).
The primers Xi1, X16X3 and Xi3R were used in the first round of PCR
(21 cycles of 50 sec at 94°C, 20 sec at 56°C and 50 sec at 72°C). A
1 µl aliquot of the first round reaction was used with the primers Xi1i,
X16X3i and Xi3Ri in a second round of amplification (31 cycles of
50 sec at 94°C, 20 sec at 56°C and 50 sec at 72°C).
Immunofluorescence staining
Preimplantation embryos were fixed with 2% paraformaldehyde in PBS
for 10 min and permeabilized in 0.5% Triton X-100 in PBS for 5 min.
After blocking with 1% goat serum in PBS for 30 min, embryos were
incubated first with the primary antibody 7B4 and then with the sec-
ondary antibody (DTAF-conjugated goat anti-mouse antibody;
Dianova), each for 30 min at 37°C. The embryos were mounted in oil
and observed under a fluorescence microscope (Zeiss) or a confocal
laser scan microscope (Leica).
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Table 2
In vitro development of preimplantation embryos from
SRp20+/d intercrosses.
Genotype Blasto- Late morulae Degenerated
cysts Early morulae
blastocysts
After 1 day culture in vitro
(equivalent to 4 dpc)
+/+ 17 10 5
+/d 33 13 3
d/d 0 5 9
After 2 days culture in vitro
(equivalent to 5 dpc)
+/+ 6 – 2
+/d 11 – 4
d/d 0 – 27
Of the 147 embryos genotyped by PCR, all but 2 gave results.
Figure 3
Immunofluorescent staining of preimplantation embryos. (a) Embryos
at different stages of development were incubated with the
SRp20-specific monoclonal antibody 7B4. A FITC-conjugated goat
anti-mouse antibody was used as a secondary antibody. The upper
panels show, from left to right: an oocyte, a fertilized egg, a 2-cell
embryo, and a 4-cell embryo. The leftmost lower panel shows an 8-cell
embryo; the following two panels show blastocysts, and the last panel
is a control in which the 7B4 antibody was omitted. (b) Fourteen
embryos between the 8-cell and blastula stage from SRp20+/d
intercrosses were stained for SRp20 expression and analyzed by PCR.
Three embryos had little or no nuclear staining (arrows) and only these
embryos were homozygous for the SRp20 mutation. The right panel is
a control in which the 7B4 antibody was omitted.
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